Quanterix Co. (NASDAQ:QTRX) Short Interest Update

Quanterix Co. (NASDAQ:QTRX - Get Free Report) was the recipient of a large decline in short interest in October. As of October 31st, there was short interest totalling 1,990,000 shares, a decline of 19.4% from the October 15th total of 2,470,000 shares. Currently, 5.6% of the company's stock are sold short. Based on an average daily trading volume, of 395,000 shares, the days-to-cover ratio is presently 5.0 days.

Insiders Place Their Bets

In other Quanterix news, Director David R. Walt bought 47,000 shares of the company's stock in a transaction dated Tuesday, August 20th. The shares were acquired at an average cost of $13.29 per share, with a total value of $624,630.00. Following the completion of the transaction, the director now owns 1,487,342 shares in the company, valued at $19,766,775.18. The trade was a 3.26 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 6.90% of the stock is currently owned by company insiders.

Institutional Trading of Quanterix

Institutional investors have recently made changes to their positions in the stock. nVerses Capital LLC acquired a new stake in Quanterix in the third quarter worth approximately $60,000. SG Americas Securities LLC bought a new position in Quanterix during the third quarter valued at about $139,000. Canada Pension Plan Investment Board bought a new stake in Quanterix in the second quarter worth about $140,000. Hsbc Holdings PLC grew its stake in shares of Quanterix by 34.7% in the 2nd quarter. Hsbc Holdings PLC now owns 12,738 shares of the company's stock worth $164,000 after purchasing an additional 3,279 shares during the last quarter. Finally, Intech Investment Management LLC bought a new stake in shares of Quanterix in the 3rd quarter worth approximately $170,000. 86.48% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on QTRX shares. TD Cowen lifted their price objective on Quanterix from $13.50 to $16.00 and gave the stock a "hold" rating in a report on Wednesday. Scotiabank dropped their price target on shares of Quanterix from $32.00 to $28.00 and set a "sector outperform" rating for the company in a research note on Monday, August 12th.

Quanterix Trading Down 4.1 %

Quanterix stock traded down $0.49 during mid-day trading on Friday, reaching $11.43. The company's stock had a trading volume of 442,796 shares, compared to its average volume of 402,666. The firm has a market cap of $438.68 million, a price-to-earnings ratio of -10.75 and a beta of 1.36. The business has a 50 day moving average price of $12.97 and a 200-day moving average price of $14.01. Quanterix has a twelve month low of $10.50 and a twelve month high of $29.70.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.